Role of tissue factor in hemostasis, thrombosis, and vascular development, Arterioscler Thromb Vasc Biol, vol.24, pp.1015-1037, 2004. ,
Orchestration of coagulation protease signaling by tissue factor, Trends Cardiovasc Med, vol.12, pp.149-54, 2002. ,
Tissue factor in cancer angiogenesis and metastasis, Curr Opin Hematol, vol.3, pp.379-84, 1996. ,
Diverse functions of protease receptor tissue factor in inflammation and metastasis, Immunol Res, vol.21, pp.289-92, 2000. ,
Regulation of functions of vascular wall cells by tissue factor pathway inhibitor: basic and clinical aspects, Arterioscler Thromb Vasc Biol, vol.22, pp.539-587, 2002. ,
Tumor cell adhesion and migration supported by interaction of a receptor-protease complex with its inhibitor, J Clin Invest, vol.104, pp.1213-1234, 1999. ,
Anti-angiogenic mechanisms and efficacy of the low molecular weight heparin, tinzaparin: anti-cancer efficacy, Oncol Rep, vol.12, pp.683-691, 2004. ,
Tissue factor, thrombin, and cancer, Chest, vol.124, pp.58-68, 2003. ,
Elevated plasma levels of the factor Xa-TFPI complex in cancer patients, Thromb Res, vol.105, pp.33-36, 2002. ,
Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis, Blood, vol.101, pp.4387-92, 2003. ,
cDNA cloning and mRNA expression of a serine proteinase inhibitor secreted by cancer cells: identification as placental protein 5 and tissue factor pathway inhibitor-2, J Biochem (Tokyo), vol.116, pp.939-981, 1994. ,
Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor, Biochemistry, vol.35, pp.266-72, 1996. ,
Differential role of tissue factor pathway inhibitors 1 and 2 in melanoma vasculogenic mimicry, Cancer Res, vol.63, pp.5381-5390, 2003. ,
Regulation of ProMMP-1 and ProMMP-3 activation by tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor, Biochem Biophys Res Commun, vol.255, pp.94-102, 1999. ,
Role of tissue factor pathway inhibitor-2 (TFPI-2) in amelanotic melanoma (C-32) invasion, Clin Exp Metastasis, vol.18, pp.303-311, 2000. ,
Expression of tissue factor pathway inhibitor 2 inversely correlates during the progression of human gliomas, Clin Cancer Res, vol.7, pp.570-576, 2001. ,
Transcriptional silencing of the TFPI-2 gene by promoter hypermethylation in choriocarcinoma cells, Biol Chem, vol.384, pp.1029-1063, 2003. ,
URL : https://hal.archives-ouvertes.fr/hal-02127398
Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells, Oncogene, vol.22, pp.4509-4525, 2003. ,
Methylation of TFPI-2 gene is not the sole cause of its silencing, Int J Oncol, vol.22, pp.843-851, 2003. ,
Expression and methylation status of tissue factor pathway inhibitor-2 gene in non-smallcell lung cancer, Br J Cancer, vol.92, pp.775-83, 2005. ,
Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma, Oncogene, vol.24, pp.850-858, 2005. ,
Immunohistochemical localization of tissue factor pathway inhibitor-2 in human tumor tissue, Thromb Haemost, vol.90, pp.140-146, 2003. ,
The effect of human tissue factor pathway inhibitor-2 on the growth and metastasis of fibrosarcoma tumors in athymic mice, Blood, vol.103, pp.1069-77, 2004. ,
Low-molecular-weight heparins in thrombosis and cancer: emerging links, Cardiovasc Drug Rev, vol.22, pp.121-155, 2004. ,